Sanofi India Ltd
Healthcare | Small Cap
Sanofi India Ltd. presents a mixed financial picture, characterized by exceptional stability but significant performance challenges. The company's greatest strength is its virtually debt-free status, which provides a strong cushion against financial risks and economic volatility. Operationally, it appears to manage its inventory and customer payments with notable efficiency. However, these strengths are contrasted by considerable weaknesses in key areas. The company is currently experiencing a lack of growth across revenues, profits, and assets, indicating a period of stagnation. Profitability is a major concern, with margins and returns on investment being very low. Furthermore, its capacity to cover short-term expenses with available liquid cash is limited. The future outlook is one of stability without growth; while the company is not in immediate financial danger due to its low debt, its inability to expand and generate profits poses a significant long-term challenge.
Latest Report
View AllLatest News
View AllHDFC Bank, Polycab India, Tata Communications, Sanofi Dividend Record Date: Last Day To Buy Shares To Qualify
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.00
- Financial Ratio3.60
- Profitability Ratio2.00
- Efficiency Ratio4.67
- Coverage Ratio2.00
- Solvency Ratio8.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthBearish
Sanofi India Ltd. presents a mixed financial picture, characterized by exceptional stability but significant performance challenges. The company's greatest strength is its virtually debt-free status, which provides a strong cushion against financial risks and economic volatility. Operationally, it appears to manage its inventory and customer payments with notable efficiency. However, these strengths are contrasted by considerable weaknesses in key areas. The company is currently experiencing a lack of growth across revenues, profits, and assets, indicating a period of stagnation. Profitability is a major concern, with margins and returns on investment being very low. Furthermore, its capacity to cover short-term expenses with available liquid cash is limited. The future outlook is one of stability without growth; while the company is not in immediate financial danger due to its low debt, its inability to expand and generate profits poses a significant long-term challenge.
Latest Report
View AllLatest News
View AllHDFC Bank, Polycab India, Tata Communications, Sanofi Dividend Record Date: Last Day To Buy Shares To Qualify
Overall Valuation Score
P/E RATIO (TTM)
24.84
Industry Median
34.78
Small Cap Median
28.42
P/E RATIO
18.59
P/B RATIO
8.93
Industry Median
11.62
Small Cap Median
8.93
P/S RATIO
3.87
Industry Median
6.05
Small Cap Median
3.87
Others
PEG RATIO
0.00
EV/EBITDA RATIO
13.17
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹3341 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Concall Report⬤5th Mar 26
Investor Conference Call – Feb 26, 2026
NEUTRAL SENTIMENT
Quarterly Report⬤25th Feb 26
Quarterly Financial Results Q3 FY 2025-26
BULLISH SENTIMENT
The company's growth prospects appear weak across the board. The analysis reveals a lack of expansion in key areas, including sales, operating profits, and net income. Additionally, the company is not significantly growing its asset base, which suggests limited investment in future expansion. This overall stagnation is a significant concern, as it points to a business that is struggling to increase its market share or operational scale. A lack of growth can impact long-term competitiveness and shareholder value.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | |||||
| Operating Profit Growth Rate | |||||
| Earnings Per Share (EPS) Growth | |||||
| Asset Growth Rate | |||||
| Net Income Growth Rate |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial metrics present a mixed view, leaning towards average. While it demonstrates strong discipline in managing its capital expenditures, indicating a conservative approach to spending on large projects, its performance on key shareholder-value metrics is weak. Measures like earnings per share and dividends per share are low, suggesting limited returns to investors. The company's intrinsic value on a per-share basis is also not a strong point. The overall picture is one of conservative financial management but weak direct returns to shareholders.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | |||||
| Cash Earnings Per Share (Cash EPS) | |||||
| Book Value Per Share | |||||
| Dividend Per Share (DPS) | |||||
| Capital Expenditures (CapEx) |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is a significant area of weakness. Across all key metrics, it struggles to convert revenue into profit effectively. Margins are thin, and the returns generated from its assets, equity, and employed capital are all low. This indicates fundamental challenges in its business model or cost structure. Poor profitability impacts every aspect of the business, from its ability to reinvest for growth to its capacity to reward shareholders, and stands out as a core issue for the company.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Equity (ROE) | |||||
| Return on Assets (ROA) | |||||
| Operating Margin | |||||
| Net Margin |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency presents a mixed but generally positive picture. It demonstrates exceptional effectiveness in managing its working capital, particularly in converting inventory to sales and collecting payments from customers very quickly. This is a significant strength that improves cash flow. However, this is contrasted by a less effective use of its larger asset base, including fixed assets and total capital, to generate revenue. While day-to-day operations are run efficiently, the overall productivity of its long-term investments appears to be an area with room for improvement.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | |||||
| Inventory Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover Ratio | |||||
| Days Sales in Inventory Ratio | N/A | N/A | N/A | N/A | N/A |
| Receivable Days | |||||
| Capital Turnover Ratio |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's ability to cover its financial obligations, such as interest and dividend payments, from its earnings appears weak. This indicates that profits are low relative to these commitments, which could pose a risk to financial stability. Specifically, the cushion for covering dividend payments is thin, suggesting that they may not be sustainable if profits decline further. This low coverage points to a reduced margin of safety and potential pressure on cash flow to meet shareholder and creditor obligations.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | |||||
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits an exceptionally strong solvency position, primarily driven by its minimal to non-existent reliance on debt financing. This indicates a very low risk of financial insolvency, as the company does not have significant long-term obligations to external lenders. Its financial structure is predominantly supported by its own funds rather than borrowing. This robust, debt-averse stance provides substantial protection against economic downturns and interest rate volatility, marking a key strength in its long-term financial health and stability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | |||||
| Debt to Equity Ratio | |||||
| Equity Ratio | |||||
| Debt To Asset Ratio |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position indicates potential challenges in meeting its short-term obligations using its most liquid assets. The amount of cash and assets easily convertible to cash is low compared to immediate liabilities. This suggests a tight management of working capital, which can be efficient but also carries risk if unforeseen expenses arise. The cash generated from core business operations is also insufficient to cover current debts, implying a reliance on other funding sources for day-to-day financial needs. This position could constrain financial flexibility in the short term.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | |||||
| Quick Ratio | |||||
| Cash Ratio | |||||
| Operating Cash Flow Ratio |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Granules India Ltd | 7.73 | 32.77 | Highly Overvalued | 1185.00 | 16.17 | 595.00 |
| 2 | FDC Ltd | 7.64 | 22.52 | Neutral | 346.00 | 17.56 | 281.00 |
| 3 | Supriya Lifescience Ltd | 7.46 | 35.88 | Highly Overvalued | 294.00 | 25.98 | 209.00 |
| 4 | Aarti Pharmalabs Ltd | 7.46 | 35.90 | Neutral | 369.00 | 19.44 | 175.00 |
| 5 | Innova Captab Ltd | 7.36 | 38.55 | Overvalued | 243.00 | 14.63 | 141.00 |
| 6 | Akums Drugs & Pharmaceuticals Ltd | 7.28 | 37.30 | Overvalued | 522.00 | 7.09 | 256.00 |
| 7 | Marksans Pharma Ltd | 7.24 | 28.16 | Neutral | 601.00 | 6.64 | 420.00 |
| 8 | Hikal Ltd | 7.13 | -51.71 | Neutral | 220.00 | -3.95 | -49.00 |
| 9 | Shilpa Medicare Ltd | 5.94 | 44.32 | Highly Overvalued | 435.00 | 6.80 | 243.00 |
| 10 | Natco Pharma Ltd | 5.69 | 11.22 | Neutral | 1436.00 | 71.55 | 1418.00 |
| 11 | Strides Pharma Science Ltd | 5.55 | 18.41 | Undervalued | 925.00 | 19.92 | 575.00 |
| 12 | Jeena Sikho Lifecare Ltd | 5.52 | 31.22 | Neutral | 349.00 | 17.87 | 222.00 |
| 13 | Orchid Pharma Ltd | 4.85 | 241.74 | Neutral | 41.00 | 8.91 | 21.00 |
| 14 | Sequent Scientific Ltd | 4.61 | 293.05 | Overvalued | 162.00 | 0.63 | 32.00 |
| 15 | Sun Pharma Advanced Research Company Ltd | 4.35 | 4.97 | Neutral | 1599.00 | 47.83 | 1553.00 |
| 16 | Zota Health Care Ltd | 3.97 | -61.25 | Neutral | 19.00 | 8.06 | -74.00 |
| 17 | Sanofi India Ltd | 3.45 | 18.59 | Neutral | 491.00 | 134.52 | 413.00 |
| 18 | Procter & Gamble Health Ltd | 3.45 | 31.71 | Neutral | 457.00 | 196.94 | 327.00 |
Management demonstrates excellent operational and financial prudence, evidenced by high capital efficiency (ROCE 55.46%, ROE 44.5%), a virtually debt-free balance sheet, and efficient working capital management. Operating margins remain stable and healthy. However, these strengths are counterbalanced by significant weaknesses in driving growth, with stagnant sales and a sharp decline in annual net profit. The consistent reduction in FII holding also indicates waning confidence from institutional investors. The overall impression is mixed, showcasing strong control over existing operations but struggling to expand the business and deliver growth.
Financial Performance & Growth
The company's growth profile is weak, marked by stagnation in revenue and a significant contraction in profitability. Annual sales grew by a marginal 0.86% in the latest year, with the TTM growth at 1%. More concerning is the TTM net profit, which declined by 25%. This has led to a sharp fall in the Net Profit Margin from 30.2% in Dec 2023 to 20.5% in Dec 2024. While recent quarterly performance shows some recovery in YOY profit growth, the overall annual trend points to a significant challenge in sustaining financial expansion. Operating margins have remained stable at around 24%, indicating core operational costs are under control, but this has not been sufficient to prevent the erosion of net profit.
| Metric | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|
| Annual Sales Growth (%) | - | 0.86% | 1.0% |
| Compounded Profit Growth (%) | - | - | -25.0% |
| Net Profit Margin (%) | 30.2% | 20.5% | - |
Capital Efficiency & Returns
Management has demonstrated excellent capital efficiency. The company generates outstanding returns, with a current ROCE of 55.46% and ROE of 44.5%. These metrics indicate highly productive use of both capital and shareholder equity. A significant improvement is seen in working capital management, as the Cash Conversion Cycle (CCC) has been drastically reduced from 167 days to 77 days. This reflects enhanced efficiency in managing inventory and receivables. The Asset Turnover ratio has also shown a slight improvement, indicating that assets are being utilized effectively to generate sales. These strong efficiency ratios are a key management strength.
| Metric | Dec 2023 | Dec 2024 |
|---|---|---|
| ROCE (%) | - | 49.0% |
| ROE (%) | 47.0% | 44.5% |
| Cash Conv. Cycle (Days) | 167 | 77 |
| Asset Turnover | 1.16 | 1.25 |
Financial Health & Prudence
The company's financial health is exceptionally strong, reflecting prudent financial management. It is virtually debt-free, with borrowings primarily consisting of lease liabilities, resulting in a negligible Debt-to-Equity ratio of 0.02. This robust balance sheet provides significant financial stability. The Interest Coverage Ratio is extremely high at over 245x, indicating that operating profits can comfortably cover interest obligations many times over. Furthermore, the company has a consistent history of sharing profits with shareholders, maintaining a healthy Dividend Payout ratio of around 65% in the last two years.
| Metric | Dec 2023 | Dec 2024 |
|---|---|---|
| Debt / Equity Ratio | 0.02 | 0.02 |
| Interest Coverage Ratio | - | 245.5x |
| Dividend Payout (%) | 64% | 65% |
Shareholding & Ownership Structure
The ownership structure reflects strong promoter conviction but also shows a notable shift in institutional interest. Promoter holding is high and has remained stable at 60.40% for many years, signaling long-term commitment. Domestic Institutional Investors (DIIs) have steadily increased their stake, indicating growing domestic confidence. However, this is contrasted by a persistent decline in Foreign Institutional Investor (FII) holding, which has fallen significantly over the past several years. This divergence in institutional sentiment presents a mixed but overall solid ownership profile.
| Metric | Mar 2017-2019 (Avg) | Mar 2020-2022 (Avg) | Mar 2023-2024 (Avg) |
|---|---|---|---|
| Promoter Holding (%) | 60.40% | 60.40% | 60.40% |
| FII Holding (%) | 13.05% | 10.73% | 6.41% |
| DII Holding (%) | 15.33% | 17.45% | 21.17% |
The overall risk profile is moderate. The company's virtually debt-free status and high liquidity significantly mitigate financial distress risk. However, the business faces significant performance risk, evidenced by negative profit growth and stagnant sales. A key area of concern is accounting quality, with large and recurring exceptional items impacting the transparency and predictability of core earnings. The declining FII ownership further adds a layer of market sentiment risk. While the balance sheet provides a strong safety net, the combination of poor growth performance and earnings quality concerns presents a material risk profile.
Accounting Quality Concerns
A notable risk is the presence of large and recurring exceptional items in the profit and loss statement. In Dec 2023, exceptional items amounted to 256 Cr, representing 33.4% of the Profit Before Tax. In Dec 2024, this figure was 62 Cr, or 11.7% of PBT. The recurrence of such significant, non-operating items reduces the clarity of the company's core operational earnings. This practice complicates the assessment of sustainable profitability and introduces a level of unpredictability into financial analysis, which constitutes a concern regarding earnings quality.
| Metric | Dec 2023 | Dec 2024 |
|---|---|---|
| Exceptional Items (Cr) | 256 | 62 |
| Exceptional Items as % of PBT | 33.4% | 11.7% |
Business Performance Risk
The company faces a significant business risk from its inability to generate growth. TTM sales growth is nearly flat at 1%, while TTM profit growth is negative at -25%. This underperformance is also reflected in the stock's price, with a 1-year CAGR of -50%. Such a steep decline in profitability and market valuation points to fundamental challenges in the company's operations or market positioning that are not being effectively addressed.
| Metric | TTM | 1-Year CAGR |
|---|---|---|
| Sales Growth (%) | 1% | - |
| Profit Growth (%) | -25% | - |
| Stock Price CAGR | - | -50% |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103350.35Bearish
- SMA 203332.46Bullish
- SMA 503258.05Bullish
- EMA 103342.35Bearish
- EMA 203328.45Bullish
- EMA 503281.70Bullish
- DEMA 103349.69Bearish
- DEMA 203361.29Bearish
- DEMA 503339.61Bearish
- TEMA 103342.58Bearish
- TEMA 203356.01Bearish
- TEMA 503371.22Bearish
- MACD22.58Bearish
- ADX40.57Strong Trend
- IndicatorValueSignal
- RSI55.97Neutral
- CCI30.14Neutral
- ROC 90.03Bullish
- ROC 140.97Bullish
- ROC 251.80Bullish
- Stoch K50.83Neutral
- Stoch D52.27Neutral
- IndicatorValueSignal
- BB Upper3377.05Neutral
- BB Middle3332.46Neutral
- BB Lower3287.86Neutral
- ATR26.12Low Volatility
- IndicatorValueSignal
- MFI59.99Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103337.76Bearish
- SMA 203311.79Bullish
- SMA 503227.71Bullish
- EMA 103333.60Bullish
- EMA 203304.08Bullish
- EMA 503253.74Bullish
- DEMA 103357.62Bearish
- DEMA 203357.15Bearish
- DEMA 503292.06Bullish
- TEMA 103349.19Bearish
- TEMA 203370.85Bearish
- TEMA 503344.85Bearish
- MACD39.15Bearish
- ADX42.71Strong Trend
- IndicatorValueSignal
- RSI60.20Neutral
- CCI69.58Neutral
- ROC 90.82Bullish
- ROC 140.55Bullish
- ROC 255.84Bullish
- Stoch K59.09Neutral
- Stoch D68.19Neutral
- IndicatorValueSignal
- BB Upper3384.57Neutral
- BB Middle3311.79Neutral
- BB Lower3239.01Neutral
- ATR35.93Low Volatility
- IndicatorValueSignal
- MFI69.67Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103313.71Bullish
- SMA 203237.34Bullish
- SMA 503208.61Bullish
- EMA 103303.99Bullish
- EMA 203264.67Bullish
- EMA 503248.34Bullish
- DEMA 103352.89Bearish
- DEMA 203313.31Bullish
- DEMA 503219.50Bullish
- TEMA 103364.04Bearish
- TEMA 203355.33Bearish
- TEMA 50N/AN/A
- MACD40.66Bullish
- ADX29.89Strong Trend
- IndicatorValueSignal
- RSI62.13Neutral
- CCI93.70Neutral
- ROC 92.34Bullish
- ROC 144.91Bullish
- ROC 253.65Bullish
- Stoch K87.34Overbought
- Stoch D88.67Overbought
- IndicatorValueSignal
- BB Upper3401.99Neutral
- BB Middle3237.34Neutral
- BB Lower3072.68Neutral
- ATR52.33Low Volatility
- IndicatorValueSignal
- MFI62.90Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103216.33Bullish
- SMA 203194.83Bullish
- SMA 503315.85Bullish
- SMA 1003555.88Bearish
- SMA 2004064.68Bearish
- EMA 103245.84Bullish
- EMA 203232.01Bullish
- EMA 503322.64Bullish
- EMA 1003559.55Bearish
- EMA 2004027.39Bearish
- DEMA 103290.15Bullish
- DEMA 203215.30Bullish
- DEMA 503119.06Bullish
- DEMA 1003062.57Bullish
- DEMA 2003222.85Bullish
- TEMA 103334.37Bullish
- TEMA 203266.78Bullish
- TEMA 503169.02Bullish
- TEMA 1003074.79Bullish
- TEMA 2002908.71Bullish
- MACD-3.55Bullish
- ADX24.82Weak Trend
- IndicatorValueSignal
- RSI62.92Neutral
- CCI241.81Overbought
- ROC 148.83Bullish
- ROC 253.66Bullish
- Stoch K88.88Overbought
- Stoch D78.58Neutral
- IndicatorValueSignal
- BB Upper3326.50Overbought
- BB Middle3194.83Neutral
- BB Lower3063.16Neutral
- ATR79.64High Volatility
- IndicatorValueSignal
- MFI65.66Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 203511.15Bearish
- SMA 504301.74Bearish
- EMA 203514.42Bearish
- EMA 504155.49Bearish
- DEMA 203050.84Bullish
- DEMA 503349.77Bearish
- TEMA 203058.82Bullish
- TEMA 502911.69Bullish
- MACD-336.03Bullish
- ADX45.45Strong Trend
- IndicatorValueSignal
- RSI28.09Oversold
- CCI-114.29Oversold
- ROC 14-17.52Bearish
- ROC 25-23.30Bearish
- Stoch K9.68Oversold
- Stoch D6.63Oversold
- IndicatorValueSignal
- BB Upper4179.89Neutral
- BB Middle3511.15Neutral
- BB Lower2842.41Neutral
- ATR165.84Low Volatility
- IndicatorValueSignal
- MFI31.46Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 63630.67Bearish
- SMA 124411.90Bearish
- SMA 245317.29Bearish
- EMA 63641.20Bearish
- EMA 124183.94Bearish
- EMA 244634.18Bearish
- DEMA 63098.57Bearish
- DEMA 123421.82Bearish
- DEMA 244270.74Bearish
- TEMA 63054.11Bullish
- TEMA 122994.11Bullish
- TEMA 243671.45Bearish
- MACD-74.82Bearish
- ADX25.90Strong Trend
- IndicatorValueSignal
- RSI41.24Neutral
- CCI-101.61Oversold
- ROC 25-35.86Bearish
- ROC 50-28.80Bearish
- Stoch K20.13Neutral
- Stoch D46.56Neutral
- IndicatorValueSignal
- BB Upper7262.46Neutral
- BB Middle5032.39Neutral
- BB Lower2802.32Neutral
- ATR572.73Low Volatility
- IndicatorValueSignal
- MFI15.29Oversold